THERAPY OF PANCREATIC CARCINOMAS (PACA) TRANSPLANTATION TUMORS WITH ANTI-CA19-9-I-131 AS WELL AS ANTI-CA19-9+ANTI-CEA-I-131

被引：0
|
作者：
KLAPDOR, R [1 ]
LANDER, S [1 ]
BAHLO, M [1 ]
MONTZ, R [1 ]
机构：
[1] UNIV HAMBURG,MED KERNKLIN & POLIKLIN,NUKL MED ABT,D-2000 HAMBURG 13,FED REP GER
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 1986年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [31] Combination of the anti-apoptotic and pro-apoptotic microRNAs expression and the anti-apoptotic protein XIAP with Serum CA19-9 in the diagnosis of pancreatic adenocarcinoma
    Cirino, Mucio Luiz de Assis
    Neto, Fermino Sanches Lizarte
    Filiputti, Vitor Barioni
    Fadel, Patricia Ciciliato
    Tirapelli, Daniela Pretti da Cunha
    Kemp, Rafael
    Sankarankutty, Ajith Kumar
    dos Santos, Jose Sebastiao
    FASEB JOURNAL, 2019, 33
  • [32] A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
    Meyer, Tim
    Gaya, Andrew M.
    Dancey, Gairin
    Stratford, Michael R. L.
    Othman, Shokri
    Sharma, Surinder K.
    Wellsted, David
    Taylor, N. Jane
    Stirling, J. James
    Poupard, Linda
    Folkes, Lisa K.
    Chan, Pei-san
    Pedley, R. Barbara
    Chester, Kerry A.
    Owen, Karen
    Violet, John A.
    Malaroda, Alessandra
    Green, Alan J.
    Buscombe, John
    Padhani, Anwar R.
    Rustin, Gordon J.
    Begent, Richard H.
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4484 - 4492
  • [33] Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer
    Gong, Xuyang
    Zhang, Heng
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (07)
  • [34] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors
    Smigielski, Jacek A.
    Piskorz, Lukasz
    Wawrzycki, Marcin
    Dobielski, Przemyslaw
    Pikala, Malgorzata
    Jablonski, Slawomir
    Brocki, Marian
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (04) : 677 - 683
  • [35] MULTIMODALITY TREATMENT OF PRIMARY NONRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA WITH I-131 ANTI-CEA - A RADIATION-THERAPY-ONCOLOGY-GROUP STUDY
    STILLWAGON, GB
    ORDER, SE
    KLEIN, JL
    LEICHNER, PK
    LEIBEL, SA
    SIEGELMAN, SS
    FISHMAN, EK
    ETTINGER, DS
    HAULK, T
    KOPHER, K
    BROWN, SM
    FINNEY, K
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (05): : 687 - 695
  • [36] The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer
    Wang, Ren-Jie
    Song, Bao-Rong
    Peng, Jun-Jie
    Cai, Guo-Xiang
    Liu, Fang-Qi
    Wang, Ming-He
    Cai, San-Jun
    Xu, Ye
    HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 994 - 999
  • [37] 检测CEA、Elasfase I、CA19-9对良性与恶性胰腺囊肿的鉴别
    张厚德
    国外医学临床生物化学与检验学分册., 1987, (04) : 44 - 44
  • [38] IMMUNOSCINTIGRAPHY IN THE DETECTION OF RECURRENT CARCINOMA - INITIAL EXPERIENCE WITH I-131 OC125 F(AB')2 AND I-131 19-9 F(AB')2,ANTI-ACE F(AB')2 MONOCLONAL-ANTIBODIES
    MESTAS, D
    BONAFOUS, J
    FERRIERE, P
    DAUPLAT, J
    VEYRE, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 321 - 321
  • [39] An Engineered Chimeric, Fc Mutated, Anti-CA19-9 scFv-Fc for Imaging Pancreas Cancer
    Rochefort, M. M.
    Girgis, M. D.
    Knowles, S.
    Bergara, F.
    Olafsen, T.
    Tomlinson, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S44 - S44
  • [40] An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles
    Girgis, Mark D.
    Federman, Noah
    Rochefort, Matthew M.
    McCabe, Katelyn E.
    Wu, Anna M.
    Nagy, Jon O.
    Denny, Christopher
    Tomlinson, James S.
    JOURNAL OF SURGICAL RESEARCH, 2013, 185 (01) : 45 - 55
12345